- Home
- AIOT vs IMTX Comparison
AIOT vs IMTX Comparison
Compare AIOT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIOT
- IMTX
- Stock Information
- Founded
- AIOT 1993
- IMTX N/A
- Country
- AIOT United States
- IMTX Germany
- Employees
- AIOT N/A
- IMTX N/A
- Industry
- AIOT Telecommunications Equipment
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIOT Telecommunications
- IMTX Health Care
- Exchange
- AIOT Nasdaq
- IMTX Nasdaq
- Market Cap
- AIOT 594.8M
- IMTX 653.9M
- IPO Year
- AIOT N/A
- IMTX N/A
- Fundamental
- Price
- AIOT $4.57
- IMTX $6.56
- Analyst Decision
- AIOT Strong Buy
- IMTX Strong Buy
- Analyst Count
- AIOT 4
- IMTX 4
- Target Price
- AIOT $10.50
- IMTX $14.67
- AVG Volume (30 Days)
- AIOT 1.7M
- IMTX 405.6K
- Earning Date
- AIOT 08-07-2025
- IMTX 08-12-2025
- Dividend Yield
- AIOT N/A
- IMTX N/A
- EPS Growth
- AIOT N/A
- IMTX N/A
- EPS
- AIOT N/A
- IMTX N/A
- Revenue
- AIOT $362,515,000.00
- IMTX $155,801,989.00
- Revenue This Year
- AIOT $20.99
- IMTX N/A
- Revenue Next Year
- AIOT $9.89
- IMTX $1.92
- P/E Ratio
- AIOT N/A
- IMTX N/A
- Revenue Growth
- AIOT 169.28
- IMTX 93.56
- 52 Week Low
- AIOT $3.70
- IMTX $3.30
- 52 Week High
- AIOT $8.71
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- AIOT 51.91
- IMTX 66.69
- Support Level
- AIOT $4.37
- IMTX $5.70
- Resistance Level
- AIOT $4.73
- IMTX $6.57
- Average True Range (ATR)
- AIOT 0.18
- IMTX 0.33
- MACD
- AIOT 0.06
- IMTX 0.05
- Stochastic Oscillator
- AIOT 74.19
- IMTX 99.50
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.